[
  {
    "id": "S1",
    "section": "Understanding Alzheimer's Disease",
    "questions": [
      {
        "id": "S1Q1",
        "question": "What are the recent statistics regarding Alzheimer's disease's prevalence and impact in the United States?",
        "importance": "critical",
        "keywords": [
          "Alzheimer's disease",
          "statistics",
          "impact"
        ]
      },
      {
        "id": "S1Q2",
        "question": "Why is early diagnosis important despite the lack of effective treatment for Alzheimer's disease?",
        "importance": "high",
        "keywords": [
          "early diagnosis",
          "importance",
          "treatment"
        ]
      }
    ]
  },
  {
    "id": "S2",
    "section": "Changes in Diagnostic Guidelines",
    "questions": [
      {
        "id": "S2Q1",
        "question": "How have the diagnostic guidelines for Alzheimer's disease changed over the past 27 years?",
        "importance": "critical",
        "keywords": [
          "diagnostic guidelines",
          "changes",
          "Alzheimer's disease"
        ]
      },
      {
        "id": "S2Q2",
        "question": "What are the three stages of Alzheimer's disease as defined by the new guidelines?",
        "importance": "high",
        "keywords": [
          "stages",
          "guidelines",
          "diagnosis"
        ]
      }
    ]
  },
  {
    "id": "S3",
    "section": "Biomarkers and Research Initiatives",
    "questions": [
      {
        "id": "S3Q1",
        "question": "What types of biomarkers are being researched to identify Alzheimer's disease at earlier stages?",
        "importance": "critical",
        "keywords": [
          "biomarkers",
          "research",
          "Alzheimer's disease"
        ]
      },
      {
        "id": "S3Q2",
        "question": "How is the Alzheimer's Disease Neuroimaging Initiative (ADNI) contributing to understanding the disease?",
        "importance": "high",
        "keywords": [
          "ADNI",
          "research study",
          "longitudinal"
        ]
      }
    ]
  },
  {
    "id": "S4",
    "section": "Public Involvement and Future Perspectives",
    "questions": [
      {
        "id": "S4Q1",
        "question": "How can the public participate in clinical trials related to Alzheimer's disease?",
        "importance": "high",
        "keywords": [
          "public involvement",
          "clinical trials",
          "Alzheimer's disease"
        ]
      },
      {
        "id": "S4Q2",
        "question": "What potential benefits could arise from knowing the early signs of Alzheimer's disease?",
        "importance": "optional",
        "keywords": [
          "early signs",
          "benefits",
          "awareness"
        ]
      }
    ]
  }
]